Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Remicade (infliximab) and Humira (adalimumab) are both biologic disease-modifying antirheumatic drug (DMARDs) used to treat various autoimmune conditions, but they have some key differences. Remicade is given through an IV infusion by a healthcare provider, while Humira is a subcutaneous injection that you can administer yourself at home. Remicade is typically given every 6 to 8 weeks, whereas Humira is usually injected every other week. Both medications are available as a brand name, but have several biosimilars available that may make it more affordable. Remicade and Humira can raise the risk of serious infections and certain cancers, but Remicade has a higher risk of causing infusion-related reactions since it is administered intravenously. Additionally, Remicade is not recommended for people with moderate or severe heart failure, while Humira can be used with caution in those with heart conditions.
Remicade (infliximab)
Humira (adalimumab)
Remicade (infliximab)
Humira (adalimumab)
Summary of Remicade vs. Humira
Summary for Biologic DMARD
Prescription only
Remicade (infliximab) is an injectable medication used to treat many autoimmune conditions, including ulcerative colitis and Crohn's disease. It's given through an intravenous (IV) infusion by a healthcare provider.
Summary for TNF blocker
Prescription only
Humira (adalimumab) is an injection used to treat many different autoimmune conditions like rheumatoid arthritis, Crohn's disease, ulcerative colitis, and plaque psoriasis. As a TNF blocker, the medication works by blocking a protein that causes inflammation in your body. It's given as a shot under the skin once every 1 to 2 weeks, depending on your condition. Humira (adalimumab) doesn't have a true generic, but there are several similar versions called biosimilars. Common side effects include infections, injection site reactions, and headache.
•Urinary tract infection (UTI) or bladder infection (8%)
Note: The side effects listed above were reported by adults with rheumatoid arthritis and are similar to those seen in people using Humira (adalimumab) for other conditions.